Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CACNB4 | O00305 | 1/20 | 0.38 |
| ▸ | CACNA1A | O00555 | 1/20 | 0.38 |
| ▸ | CACNA1G | O43497 | 1/20 | 0.38 |
| ▸ | CACNG3 | O60359 | 1/20 | 0.38 |
| ▸ | CACNA1F | O60840 | 1/20 | 0.38 |
| ▸ | CACNA1H | O95180 | 1/20 | 0.38 |
| ▸ | CACNB3 | P54284 | 1/20 | 0.38 |
| ▸ | CACNA2D1 | P54289 | 1/20 | 0.38 |
| ▸ | CACNG7 | P62955 | 1/20 | 0.38 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.38 |
| ▸ | CACNA1D | Q01668 | 1/20 | 0.38 |
| ▸ | CACNB1 | Q02641 | 1/20 | 0.38 |
| ▸ | CACNG1 | Q06432 | 1/20 | 0.38 |
| ▸ | CACNB2 | Q08289 | 1/20 | 0.38 |
| ▸ | CACNA1S | Q13698 | 1/20 | 0.38 |
| ▸ | CACNA1C | Q13936 | 1/20 | 0.38 |
| ▸ | CACNA1E | Q15878 | 1/20 | 0.38 |
| ▸ | CACNA2D4 | Q7Z3S7 | 1/20 | 0.38 |
| ▸ | CACNA2D3 | Q8IZS8 | 1/20 | 0.38 |
| ▸ | CACNG8 | Q8WXS5 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6824743 | 0.93 | HRH3 (0.39) | HRH3ADORA1GPR119KCNH2SLC16A3 | |
| SCHEMBL6921388 | 0.92 | IKBKB (0.39) | CACNB4CACNA1ACACNA1GCACNG3CACNA1F | |
| Hydrochloric Acid SCHEMBL6822212 | 0.88 | HRH3 (0.40) | HRH3ADORA1 | |
| SCHEMBL6822059 | 0.85 | HRH3 (0.37) | HRH3ADORA1SLC16A3SLC16A1 | |
| SCHEMBL6824899 | 0.85 | ADORA1 (0.38) | ADORA1 | |
| Hydrochloric Acid SCHEMBL6821473 | 0.85 | HRH3 (0.42) | HRH3ADORA1 | |
| SCHEMBL6822350 | 0.83 | ADORA1 (0.40) | ADORA1ACACBACACA | |
| SCHEMBL6821916 | 0.80 | ADORA1 (0.42) | ADORA1 | |
| SCHEMBL6822257 | 0.80 | ADORA1 (0.43) | ADORA1 | |
| SCHEMBL6821959 | 0.79 | ADORA1 (0.42) | ADORA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040110763-A1 | Pyrazolopyridine compound and pharmaceutical use thereof | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2004-06-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040110763-A1 | Pyrazolopyridine compound and pharmaceutical use thereof | ADRB1, ADRA1D, ADRB3 | CACNB4 601/4885CACNA1A 196/4885CACNA1G 324/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.